ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-21R18530
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Granulocyte Macrophage Colony Stimulating Factor GM CSF Market Research Report 2024
BUY CHAPTERS

Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Research Report 2024

Code: QYRE-Auto-21R18530
Report
November 2024
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Partner Therapeutics
Nobelpharma Co
Changchun GeneScience Pharmaceutical
North China Pharmaceutical
Amoytop Biotech
Hainan Unipul Pharmaceutical
Harbin Pharmaceutical Group
Guangzhou Baiyunshan Pharmaceutical

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market

The global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) is a glycoprotein cytokine that plays a critical role in the regulation of hematopoiesis, particularly in the production and differentiation of myeloid lineage cells, including granulocytes and macrophages. Clinically, GM-CSF is utilized in treating conditions such as neutropenia following chemotherapy or bone marrow transplantation, as it enhances immune response and reduces the risk of infections. Additionally, GM-CSF is being explored in immunotherapy for cancer and in the treatment of autoimmune diseases and pulmonary conditions like pulmonary alveolar proteinosis.
North American market for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) include Partner Therapeutics, Nobelpharma, Changchun GeneScience Pharmaceutical, North China Pharmaceutical, Amoytop Biotech, Hainan Unipul Pharmaceutical, Harbin Pharmaceutical Group, Guangzhou Baiyunshan Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Granulocyte Macrophage Colony Stimulating Factor (GM-CSF).
The Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Report

Report Metric Details
Report Name Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Partner Therapeutics, Nobelpharma, Changchun GeneScience Pharmaceutical, North China Pharmaceutical, Amoytop Biotech, Hainan Unipul Pharmaceutical, Harbin Pharmaceutical Group, Guangzhou Baiyunshan Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market report?

Ans: The main players in the Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market are Partner Therapeutics, Nobelpharma, Changchun GeneScience Pharmaceutical, North China Pharmaceutical, Amoytop Biotech, Hainan Unipul Pharmaceutical, Harbin Pharmaceutical Group, Guangzhou Baiyunshan Pharmaceutical

What are the Application segmentation covered in the Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market report?

Ans: The Applications covered in the Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market report are Infectious Disease Treatment, Cancer Treatment Support, Proteinosis Autoimmune Pulmonary Alveolar, Other

What are the Type segmentation covered in the Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market report?

Ans: The Types covered in the Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market report are Injection, Inhalation, Other

Recommended Reports

Stem Cell Markets

Cytokines & Growth Factors

Gene & Cell Therapy

1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Overview
1.1 Product Definition
1.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Type
1.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Value Comparison by Type (2024-2030)
1.2.2 Injection
1.2.3 Inhalation
1.2.4 Other
1.3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Application
1.3.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Value by Application (2024-2030)
1.3.2 Infectious Disease Treatment
1.3.3 Cancer Treatment Support
1.3.4 Proteinosis Autoimmune Pulmonary Alveolar
1.3.5 Other
1.4 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Estimates and Forecasts
1.4.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue 2019-2030
1.4.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales 2019-2030
1.4.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Competition by Manufacturers
2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Product Type & Application
2.7 Global Key Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Date of Enter into This Industry
2.8 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Competitive Situation and Trends
2.8.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Players Market Share by Revenue
2.8.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Scenario by Region
3.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region: 2019-2030
3.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region: 2019-2024
3.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region: 2025-2030
3.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region: 2019-2030
3.3.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region: 2019-2024
3.3.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region: 2025-2030
3.4 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Facts & Figures by Country
3.4.1 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2019-2030)
3.4.3 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Facts & Figures by Country
3.5.1 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2019-2030)
3.5.3 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Facts & Figures by Region
3.6.1 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (2019-2030)
3.6.3 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Facts & Figures by Country
3.7.1 Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2019-2030)
3.7.3 Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Facts & Figures by Country
3.8.1 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2019-2030)
4.1.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2019-2024)
4.1.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2025-2030)
4.1.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type (2019-2030)
4.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2019-2030)
4.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2019-2024)
4.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2025-2030)
4.2.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type (2019-2030)
4.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2019-2030)
5.1.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2019-2024)
5.1.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2025-2030)
5.1.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application (2019-2030)
5.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2019-2030)
5.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2019-2024)
5.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2025-2030)
5.2.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application (2019-2030)
5.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Partner Therapeutics
6.1.1 Partner Therapeutics Company Information
6.1.2 Partner Therapeutics Description and Business Overview
6.1.3 Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.1.5 Partner Therapeutics Recent Developments/Updates
6.2 Nobelpharma
6.2.1 Nobelpharma Company Information
6.2.2 Nobelpharma Description and Business Overview
6.2.3 Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.2.5 Nobelpharma Recent Developments/Updates
6.3 Changchun GeneScience Pharmaceutical
6.3.1 Changchun GeneScience Pharmaceutical Company Information
6.3.2 Changchun GeneScience Pharmaceutical Description and Business Overview
6.3.3 Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.3.5 Changchun GeneScience Pharmaceutical Recent Developments/Updates
6.4 North China Pharmaceutical
6.4.1 North China Pharmaceutical Company Information
6.4.2 North China Pharmaceutical Description and Business Overview
6.4.3 North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.4.5 North China Pharmaceutical Recent Developments/Updates
6.5 Amoytop Biotech
6.5.1 Amoytop Biotech Company Information
6.5.2 Amoytop Biotech Description and Business Overview
6.5.3 Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.5.5 Amoytop Biotech Recent Developments/Updates
6.6 Hainan Unipul Pharmaceutical
6.6.1 Hainan Unipul Pharmaceutical Company Information
6.6.2 Hainan Unipul Pharmaceutical Description and Business Overview
6.6.3 Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.6.5 Hainan Unipul Pharmaceutical Recent Developments/Updates
6.7 Harbin Pharmaceutical Group
6.7.1 Harbin Pharmaceutical Group Company Information
6.7.2 Harbin Pharmaceutical Group Description and Business Overview
6.7.3 Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.7.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.8 Guangzhou Baiyunshan Pharmaceutical
6.8.1 Guangzhou Baiyunshan Pharmaceutical Company Information
6.8.2 Guangzhou Baiyunshan Pharmaceutical Description and Business Overview
6.8.3 Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.8.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Chain Analysis
7.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Production Mode & Process
7.4 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Marketing
7.4.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Channels
7.4.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Distributors
7.5 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Customers
8 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Dynamics
8.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Trends
8.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Drivers
8.3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Challenges
8.4 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Partner Therapeutics
Nobelpharma Co
Changchun GeneScience Pharmaceutical
North China Pharmaceutical
Amoytop Biotech
Hainan Unipul Pharmaceutical
Harbin Pharmaceutical Group
Guangzhou Baiyunshan Pharmaceutical
List of Tables
 Table 1. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Product Type & Application
 Table 12. Global Key Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (2019-2024) & (K Units)
 Table 18. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Region (2019-2024)
 Table 19. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (2025-2030) & (K Units)
 Table 20. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Region (2025-2030)
 Table 21. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Region (2019-2024)
 Table 23. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Region (2025-2030)
 Table 25. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2019-2024) & (K Units)
 Table 27. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2025-2030) & (K Units)
 Table 28. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units) by Type (2019-2024)
 Table 51. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units) by Type (2025-2030)
 Table 52. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type (2019-2024)
 Table 53. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type (2025-2030)
 Table 54. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type (2019-2024)
 Table 57. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type (2025-2030)
 Table 58. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units) by Application (2019-2024)
 Table 61. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units) by Application (2025-2030)
 Table 62. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application (2019-2024)
 Table 63. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application (2025-2030)
 Table 64. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application (2019-2024)
 Table 67. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application (2025-2030)
 Table 68. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price (US$/Unit) by Application (2025-2030)
 Table 70. Partner Therapeutics Company Information
 Table 71. Partner Therapeutics Description and Business Overview
 Table 72. Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
 Table 74. Partner Therapeutics Recent Developments/Updates
 Table 75. Nobelpharma Company Information
 Table 76. Nobelpharma Description and Business Overview
 Table 77. Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
 Table 79. Nobelpharma Recent Developments/Updates
 Table 80. Changchun GeneScience Pharmaceutical Company Information
 Table 81. Changchun GeneScience Pharmaceutical Description and Business Overview
 Table 82. Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
 Table 84. Changchun GeneScience Pharmaceutical Recent Developments/Updates
 Table 85. North China Pharmaceutical Company Information
 Table 86. North China Pharmaceutical Description and Business Overview
 Table 87. North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
 Table 89. North China Pharmaceutical Recent Developments/Updates
 Table 90. Amoytop Biotech Company Information
 Table 91. Amoytop Biotech Description and Business Overview
 Table 92. Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
 Table 94. Amoytop Biotech Recent Developments/Updates
 Table 95. Hainan Unipul Pharmaceutical Company Information
 Table 96. Hainan Unipul Pharmaceutical Description and Business Overview
 Table 97. Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
 Table 99. Hainan Unipul Pharmaceutical Recent Developments/Updates
 Table 100. Harbin Pharmaceutical Group Company Information
 Table 101. Harbin Pharmaceutical Group Description and Business Overview
 Table 102. Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
 Table 104. Harbin Pharmaceutical Group Recent Developments/Updates
 Table 105. Guangzhou Baiyunshan Pharmaceutical Company Information
 Table 106. Guangzhou Baiyunshan Pharmaceutical Description and Business Overview
 Table 107. Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
 Table 109. Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Distributors List
 Table 113. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Customers List
 Table 114. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Trends
 Table 115. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Drivers
 Table 116. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Challenges
 Table 117. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
 Figure 2. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Type: 2023 & 2030
 Figure 4. Injection Product Picture
 Figure 5. Inhalation Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Application: 2023 & 2030
 Figure 9. Infectious Disease Treatment
 Figure 10. Cancer Treatment Support
 Figure 11. Proteinosis Autoimmune Pulmonary Alveolar
 Figure 12. Other
 Figure 13. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size (2019-2030) & (US$ Million)
 Figure 15. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (2019-2030) & (K Units)
 Figure 16. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Average Price (US$/Unit) & (2019-2030)
 Figure 17. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Report Years Considered
 Figure 18. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Share by Manufacturers in 2023
 Figure 19. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Manufacturers in 2023
 Figure 20. Global 5 and 10 Largest Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Players: Market Share by Revenue in Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in 2023
 Figure 21. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 22. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 23. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2019-2030)
 Figure 24. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Country (2019-2030)
 Figure 25. United States Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Canada Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2019-2030)
 Figure 28. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Country (2019-2030)
 Figure 29. Germany Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. France Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. U.K. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Italy Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Russia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Region (2019-2030)
 Figure 35. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Region (2019-2030)
 Figure 36. China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Japan Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. South Korea Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. India Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Australia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. China Taiwan Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2019-2030)
 Figure 44. Mexico Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Brazil Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Argentina Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Colombia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2019-2030)
 Figure 49. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Country (2019-2030)
 Figure 50. Turkey Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Saudi Arabia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. UAE Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Global Sales Market Share of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Type (2019-2030)
 Figure 54. Global Revenue Market Share of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Type (2019-2030)
 Figure 55. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price (US$/Unit) by Type (2019-2030)
 Figure 56. Global Sales Market Share of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Application (2019-2030)
 Figure 57. Global Revenue Market Share of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Application (2019-2030)
 Figure 58. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price (US$/Unit) by Application (2019-2030)
 Figure 59. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Value Chain
 Figure 60. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Production Process
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Granulocyte Colony Stimulating Factor G CSF Market Research Report 2024
Global Long acting Granulocyte Colony Stimulating Factor G CSF Market Research Report 2024
Global Human Granulocyte Macrophage Colony stimulating Factor for Injection Market Research Report 2024
Granulocyte Colony Stimulating Factor G CSF Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global PEGylated Granulocyte Colony Stimulating Factor Market Research Report 2024
Global Granulocyte Macrophage Colony Stimulating Factor GM CSF ELISA Kit Market Research Report 2024
Global Recombinant Human Granulocyte Colony Stimulating Factor Injection rhG CSF Market Research Report 2025
Global Recombinant Human GM CSF for Injection Market Research Report 2024
Global Stem Cell Growth Factors Market Research Report 2025
Global Macrophage Stimulating Protein Receptor Market Research Report 2025
Global PEG rhG CSF Market Research Report 2025
Global Human Granulocyte Colony Stimulating Factor for Injection Market Research Report 2024
Global Macrophage Colony Stimulating Factor Reagent Market Research Report 2025
Global Stem Cell Cytokines Market Research Report 2024
Global Recombinant Human Granulocyte Colony Stimulating Market Insights Forecast to 2030
Global Recombinant Human M CSF Protein Market Research Report 2025
Global Stromal Cell Derived Factor 1 Market Research Report 2024
Global Filgrastim Market Insights Forecast to 2030
Global Granulocyte Colony stimulating Factor G CSF ELISA Kit Market Research Report 2024
Global Filgrastim and Biosimilars Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions